Literature DB >> 15320877

Epitope DNA vaccines against tuberculosis: spacers and ubiquitin modulates cellular immune responses elicited by epitope DNA vaccine.

Q-M Wang1, S-H Sun, Z-L Hu, F-J Zhou, M Yin, C-J Xiao, J-C Zhang.   

Abstract

Cell-mediated immune responses are crucial in the protection against tuberculosis. In this study, we constructed epitope DNA vaccines (p3-M-38) encoding cytotoxic T lymphocyte (CTL) epitopes of MPT64 and 38 kDa proteins of Mycobacterium tuberculosis. In order to observe the influence of spacer sequence (Ala-Ala-Tyr) or ubiquitin (UbGR) on the efficacy of the two CTL epitopes, we also constructed DNA vaccines, p3-M-S(spacer)-38, p3-Ub (UbGR)-M-S-38 and p3-Ub-M-38. The immune responses elicited by the four DNA vaccines were tested in C57BL/6 (H-2b) mice. The cytotoxicity of T cells was detected by LDH-release method and by enzyme-linked immunospot assay for epitope-specific cells secreting interferon-gamma. The results showed that DNA immunization with p3-M-38 vaccine could induce epitope-specific CD8+ CTL response and that the spacer sequence (AAY) only enhanced M epitope presentation. The protein-targeting sequence (UbGR) enhanced the immunogenicity of the two epitopes. The finding that defined spacer sequences at C-terminus and protein-targeting degradation modulated the immune response of epitope string DNA vaccines will be of importance for the further development of multi-epitope DNA vaccines against tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15320877     DOI: 10.1111/j.0300-9475.2004.01442.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  14 in total

1.  Preclinical development of HIvax: Human survivin highly immunogenic vaccines.

Authors:  Peter R Hoffmann; Maddalena Panigada; Elisa Soprana; Frances Terry; Ivo Sah Bandar; Andrea Napolitano; Aaron H Rose; Fukun W Hoffmann; Lishomwa C Ndhlovu; Mahdi Belcaid; Lenny Moise; Anne S De Groot; Michele Carbone; Giovanni Gaudino; Takashi Matsui; Antonio Siccardi; Pietro Bertino
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  In silico design of a DNA-based HIV-1 multi-epitope vaccine for Chinese populations.

Authors:  Yi Yang; Weilai Sun; Jingjing Guo; Guangyu Zhao; Shihui Sun; Hong Yu; Yan Guo; Jungfeng Li; Xia Jin; Lanying Du; Shibo Jiang; Zhihua Kou; Yusen Zhou
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 3.  Peptide-Based Vaccines for Tuberculosis.

Authors:  Wenping Gong; Chao Pan; Peng Cheng; Jie Wang; Guangyu Zhao; Xueqiong Wu
Journal:  Front Immunol       Date:  2022-01-31       Impact factor: 7.561

4.  Towards the First Multiepitope Vaccine Candidate against Neospora caninum in Mouse Model: Immunoinformatic Standpoint.

Authors:  Morteza Shams; Bahman Maleki; Bahareh Kordi; Hamidreza Majidiani; Naser Nazari; Hamid Irannejad; Ali Asghari
Journal:  Biomed Res Int       Date:  2022-06-09       Impact factor: 3.246

5.  Targeting myelin proteolipid protein to the MHC class I pathway by ubiquitination modulates the course of experimental autoimmune encephalomyelitis.

Authors:  Diethilde J Theil; Jane E Libbey; Fernando Rodriguez; J Lindsay Whitton; Ikuo Tsunoda; Tobias J Derfuss; Robert S Fujinami
Journal:  J Neuroimmunol       Date:  2008-11-15       Impact factor: 3.478

Review 6.  Tuberculosis vaccine research in China.

Authors:  Douglas B Lowrie
Journal:  Emerg Microbes Infect       Date:  2012-07-25       Impact factor: 7.163

7.  Development of a humanized HLA-A2.1/DP4 transgenic mouse model and the use of this model to map HLA-DP4-restricted epitopes of HBV envelope protein.

Authors:  Zhitao Ru; Wenjun Xiao; Anthony Pajot; Zhihua Kou; Shihui Sun; Bernard Maillere; Guangyu Zhao; David M Ojcius; Yu-Chun Lone; Yusen Zhou
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

8.  A novel minigene scaffold for therapeutic cancer vaccines.

Authors:  Luigi Aurisicchio; Arthur Fridman; Ansuman Bagchi; Elisa Scarselli; Nicola La Monica; Gennaro Ciliberto
Journal:  Oncoimmunology       Date:  2014-01-16       Impact factor: 8.110

9.  A Poly(Lactic-co-Glycolic) Acid Nanovaccine Based on Chimeric Peptides from Different Leishmania infantum Proteins Induces Dendritic Cells Maturation and Promotes Peptide-Specific IFNγ-Producing CD8+ T Cells Essential for the Protection against Experimental Visceral Leishmaniasis.

Authors:  Evita Athanasiou; Maria Agallou; Spyros Tastsoglou; Olga Kammona; Artemis Hatzigeorgiou; Costas Kiparissides; Evdokia Karagouni
Journal:  Front Immunol       Date:  2017-06-13       Impact factor: 7.561

10.  The immunoreactivity of a chimeric multi-epitope DNA vaccine against IBV in chickens.

Authors:  Lang Tian; Hong-ning Wang; Dan Lu; Yun-fei Zhang; Ting Wang; Run-ming Kang
Journal:  Biochem Biophys Res Commun       Date:  2008-10-07       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.